Blocking Mammalian Target of Rapamycin (mTOR) Attenuates HIF-1α Pathways Engaged-Vascular Endothelial Growth Factor (VEGF) in Diabetic Retinopathy

Publisher： Karger

E-ISSN： 1421-9778|40|6|1570-1577

ISSN： 1015-8987

Source： Cellular Physiology and Biochemistry, Vol.40, Iss.6, 2016-12, pp. : 1570-1577

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Suppression of the proliferation of hypoxia‐Induced retinal pigment epithelial cell by rapamycin through the /mTOR/HIF‐1α/VEGF/ signaling

IUBMB LIFE, Vol. 67, Iss. 6, 2015-06 ,pp. : 446-452

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis

By Lawrence Jessica Nho Richard

International Journal of Molecular Sciences, Vol. 19, Iss. 3, 2018-03 ,pp. : 778-778

MDPI

Access to resources Recommend Favorite

Targeting the Mammalian Target of Rapamycin (mTOR) in Cancer Therapy: Lessons from Past and Future Perspectives

By Dufour Marc Dormond-Meuwly Anne Demartines Nicolas Dormond Olivier

Cancers, Vol. 3, Iss. 2, 2011-05 ,pp. : 2478-2500

MDPI

Access to resources Recommend Favorite

Chemical Inhibitors and microRNAs (miRNA) Targeting the Mammalian Target of Rapamycin (mTOR) Pathway: Potential for Novel Anticancer Therapeutics

By AlQurashi Naif Hashimi Saeed M. Wei Ming Q.

International Journal of Molecular Sciences, Vol. 14, Iss. 2, 2013-02 ,pp. : 3874-3900

MDPI

Access to resources Recommend Favorite

Current Models of Mammalian Target of Rapamycin Complex 1 (mTORC1) Activation by Growth Factors and Amino Acids

By Zheng Xu Liang Yan He Qiburi Yao Ruiyuan Bao Wenlei Bao Lili Wang Yanfeng Wang Zhigang

International Journal of Molecular Sciences, Vol. 15, Iss. 11, 2014-11 ,pp. : 20753-20769

MDPI

Access to resources Recommend Favorite